drugset / Trial / NCT01532102
Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the safety, tolerability and efficacy of the topical application of AP611074 5% gel during 6 weeks on ano-genital warts caused by human papillomavirus (HPV).
Timeline
- Start
- 2012-02-28
- Primary completion
- 2013-05-06
- Completion
- 2013-05-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AP611074 | Small molecule | 100 mg | Topical |